Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 16, 2018Molecular TherapyOpen Access

Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

GSGang ShiQYQianmei YangYZYujing Zhang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shi et al. (2018) studied this question.

synapsesocial.com/papers/6aaa075f788c57f1c6a4e591https://doi.org/10.1016/j.ymthe.2018.11.010
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Oncolytic Viruses in Cancer Treatment2016 · 594 citations
  2. 2PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations2016 · 2,464 citations
  3. 3Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study2015 · 595 citations
  4. 4The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model2016 · 90 citations